car-nk for b-cell malignancies: the elipse-1 study of cnty-101
Published 1 year ago • 103 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
3:18
allogeneic car-nk cell therapy in r/r aml/mds
-
8:54
ft596: ipsc-derived car-nk cells with engineered persistence for b-cell malignancies
-
2:56
car-nk clinical trials
-
0:40
the current status of car t and car nk cells in multiple myeloma
-
2:25
advantages of using car-nks for the treatment of hematological malignancies
-
1:03
addressing car-nk unknowns
-
3:24
an introduction to car-t and car-nk cell therapy development
-
1:15
nk cells in hematological malignancies
-
1:19
car-t vs car-nk for myeloma
-
2:20
car-transduced nk cell therapy
-
1:16
nk cell therapy update
-
1:16
the efficacy of car t-cell therapy in richter's transformation
-
0:55
ebmt 2021 highlights: car-nk
-
1:28
future prospects for nk cell therapy
-
1:17
nk-car immunotherapy: the next steps
-
1:49
are car nk-cells the future of cll therapy?
-
1:06
car-nk: improved crs and promising safety profiles in myeloma
-
2:01
cellular therapy: nk-cells as a model
-
1:09:38
upgrading the sequential therapy tool kit for b-cell malignancies